基本信息
views: 0
Career Trajectory
Bio
No content for now
Research Interests
Papers共 12 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
D.A. Sychev Sychev,O.D. Ostroumova Ostroumova,A.P. Pereverzev Pereverzev,M.S. Chernyaeva Chernyaeva,A.I. Kochetkov Kochetkov,M.V. Klepikova Klepikova, E.Yu. Ebzeeva Ebzeeva,V.A. De De
Pharmateca (2022): 10-18
D.A. Sychev Sychev,O.D. Ostroumova Ostroumova,A.I. Kochetkov Kochetkov,A.P. Pereverzev Pereverzev,M.V. Klepikova Klepikova, E.Yu. Ebzeeva Ebzeeva,V.A. De De
Pharmateca (2022): 10-15
Safety and Risk of Pharmacotherapyno. 1 (2021): 15-24
D.A. Sychev Sychev,O.D. Ostroumova Ostroumova,M.S. Chernyaeva Chernyaeva,A.P. Pereverzev Pereverzev,A.I. Kochetkov Kochetkov,T.M. Ostroumova Ostroumova,M.V. Klepikova Klepikova, E.Yu. Ebzeeva Ebzeeva,V.A. De De
Pharmateca (2021): 34-46
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practiceno. 2 (2021): 52-66
D.A. Sychev Sychev,O.D. Ostroumova Ostroumova,A.I. Kochetkov Kochetkov,A.P. Pereverzev Pereverzev,T.M. Ostroumova Ostroumova,M.V. Klepikova Klepikova, E.Yu. Ebzeeva Ebzeeva
Pharmateca (2021): 84-94
D.A. Sychev Sychev,O.D. Ostroumova Ostroumova,A.P. Pereverzev Pereverzev,A.I. Kochetkov Kochetkov,T.M. Ostroumova Ostroumova,M.V. Klepikova Klepikova, E.Yu. Ebzeeva Ebzeeva
Pharmateca (2021): 8-16
Безопасность и риск фармакотерапииno. 2 (2021): 85-94
D.A. Sychev Sychev,O.D. Ostroumova Ostroumova,A.P. Pereverzev Pereverzev,A.I. Kochetkov Kochetkov,M.V. Klepikova Klepikova, E.Yu. Ebzeeva Ebzeeva,V.A. De De
Pharmateca (2021): 41-52
Safety and Risk of Pharmacotherapyno. 2 (2021): 85-94
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn